Skip to main content
Cato Daily Podcast •

Would Wider Access to GLP-1s Throttle Addiction?

Drugs like Ozempic show potential to help those with addiction with little downside risk. How quickly can their availability be expanded? Nicholas Reville of CASPR makes his case.

Featuring
Nicholas Reville - circle portrait
Nicholas Reville

Co-founder and Executive Director, Center for Addiction Science, Policy, and Research (CASPR)

Caleb O. Brown

Caleb Brown is the director of multimedia at the Cato Institute, and the host and executive producer of the Cato Daily Podcast. He has hosted the Cato Daily Podcast since 2007 and CatoAudio since 2008.